Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001447028-25-000037)

Filing Details

Accession Number:: 0001447028-25-000037
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-02-05 16:02:16
Reporting Period:: 2025-02-04

Filing Date:: 2025-02-05
Accepted Time:: 2025-02-05 16:02:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1447028	Arbutus Biopharma Corp	ABUS	Pharmaceutical Preparations (2834)	980597776

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1496194	Christopher J. Naftzger	C/O Arbutus Biopharma Corporation 701 Veterans Circle Warminster PA 18974	General Counsel And Cco	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2025-02-04	11,333	$3.28	86,244	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on July 11, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of previous grants of restricted stock units.
Includes 1,214 and 1,263 shares acquired under the Arbutus Biopharma Corporation 2020 Employee Stock Purchase Plan on February 29, 2024 and August 30, 2024, respectively.